The Rundown cover image

Tesla Looks to End 3-Day Skid, Pharma Stock Plunges 50% After Pfizer Ends Partnership

The Rundown

00:00

Market Volatility and Year-End Reflections

This chapter analyzes recent stock market changes, highlighting Tesla's modest gains and Sangamo Therapeutics' significant decline after Pfizer's partnership withdrawal. The discussion also touches on the rise in ETF investments and concludes with a note of appreciation for the audience's support and a glimpse of future content.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app